Corporate Tech Investors

Novartis Venture Fund

Novartis Venture Fund is a corporate VC that partners with companies that are a good strategic fit.

Venture Investor Overview

Venture Investor
Novartis Venture Fund
Status
Active
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
Reinhard Ambros
Title
Executive Director
Mailing Address
100 Technology Sq.
Cambridge, MA 02139
USA
Email Address
Not Recorded

Background Information

Overview
Investing in innovative life sciences concepts for patient benefit creating attractive returns for entrepreneurs and investors.
Profile
Novartis Venture Fund LinkedIn Company Profile
Social Media
Novartis Venture Fund Company Twitter Account
Company News
Novartis Venture Fund News
Facebook
Novartis Venture Fund on Facebook
YouTube
Novartis Venture Fund on YouTube
Last Transaction
9/16/2024

Transaction History

Our records indicate that Novartis Venture Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
9/16/2024
$65,000,000
9/9/2024
$16,000,000
7/16/2024
$150,000,000
6/25/2024
$82,000,000
3/21/2024
$175,000,000
1/30/2024
$32,780,000
10/9/2023
$59,008,000
8/25/2023
$75,000,000
6/22/2023
$65,000,000
3/15/2023
$105,000,000
11/22/2022
$49,000,000
6/22/2022
$119,000,000
5/19/2022
$11,500,000
3/2/2022
$41,200,000
1/28/2022
$111,000,000
9/30/2021
$80,000,000
8/19/2021
$58,000,000
7/15/2021
$65,000,000
3/19/2021
$72,000,000
1/26/2021
$100,000,000
12/23/2020
$81,000,000
12/17/2020
$25,000,000
8/31/2020
$270,000,000
8/21/2020
$18,000,000
8/21/2020
$40,000,000
8/6/2020
$20,000,000
4/16/2020
$15,000,000
3/4/2020
$105,000,000
3/4/2020
$100,000,000
1/10/2020
$35,000,000
11/22/2019
$39,000,000
10/4/2019
$80,000,000
8/16/2019
$11,000,000
7/25/2019
$48,000,000
6/21/2019
$3,000,000
5/29/2019
$30,000,000
5/22/2019
$50,000,000
4/23/2019
$142,000,000
3/28/2019
$11,000,000
2/28/2019
$250,000,000
1/7/2019
$65,000,000
1/7/2019
$64,000,000
12/20/2018
$75,000,000
9/21/2018
$150,000,000
9/14/2018
$19,000,000
9/7/2018
$65,000,000
8/8/2018
$50,000,000
4/3/2018
$20,000,000
1/4/2018
$55,300,000
1/3/2018
$50,000,000
12/1/2017
$114,000,000
11/2/2017
$7,400,000
7/25/2017
$38,600,000
7/21/2017
$14,000,000
7/13/2017
$63,000,000
6/2/2017
$51,400,000
5/23/2017
$11,000,000
5/18/2017
$4,250,000
1/7/2017
$26,100,000
11/17/2016
$10,000,000
9/13/2016
$17,000,000
9/7/2016
$40,000,000
8/30/2016
$120,000,000
6/23/2016
$44,000,000
6/23/2016
$27,000,000
6/21/2016
$60,000,000
5/16/2016
$30,000,000
3/31/2016
Unknown
1/28/2016
$51,000,000
9/9/2015
$37,000,000
7/23/2015
$58,500,000
6/30/2015
$7,352,000
5/27/2015
Unknown
5/12/2015
$38,000,000
4/16/2015
$28,000,000
4/13/2015
$120,000,000
3/23/2015
$44,000,000
3/5/2015
$22,000,000
2/19/2015
$28,000,000
12/16/2014
$34,000,000
12/9/2014
$15,000,000
11/21/2014
$53,000,000
10/29/2014
$33,000,000
10/27/2014
$17,000,000
10/21/2014
$60,000,000
9/30/2014
$4,180,000
8/11/2014
$16,000,000
5/15/2014
$6,500,000
5/9/2014
$21,000,000
4/23/2014
$22,000,000
4/8/2014
$41,000,000
4/1/2014
$6,300,000
2/25/2014
$49,000,000
11/18/2013
$30,000,000
6/30/2013
$3,000,000
6/5/2013
$41,000,000
5/21/2013
$45,000,000
5/15/2013
$35,500,000
4/11/2013
$6,000,000
3/31/2013
$5,072,000
1/14/2013
$12,000,000
12/31/2012
$3,000,100
12/11/2012
$11,000,000
11/1/2012
$16,000,000
10/16/2012
$7,000,000
6/30/2012
$3,709,200
5/16/2012
$8,600,000
5/15/2012
$25,000,000
3/31/2012
$163,200
3/31/2012
$1,927,200
3/28/2012
$12,500,000
2/16/2012
$43,000,000
9/20/2011
$23,000,000
6/30/2011
$1,700,000
6/30/2011
$36,000,000
6/30/2011
$25,623,000
3/16/2011
$11,000,000
7/22/2010
$24,000,000
6/30/2010
$5,000,000
6/15/2010
$29,000,000
1/7/2010
$16,500,000
12/31/2009
$2,654,000
12/31/2009
$2,230,000
12/1/2009
$25,500,000
10/20/2009
$38,000,000
9/30/2009
$12,000,000
9/30/2009
$14,530,000
7/27/2009
$30,000,000
7/9/2009
$51,000,000
7/7/2009
$18,000,000
6/30/2009
$10,000,000
6/30/2009
$2,100,000
6/8/2009
$40,000,000
5/19/2009
$12,000,000
5/8/2009
$22,000,000
4/27/2009
$40,000,000

 


Investor Contacts

Title
Name
Email & Social
Managing Director
Florent Gros
  Florent Gros LinkedIn Profile  Florent Gros Twitter Account  Florent Gros News  Florent Gros on Facebook
Managing Director
Anja König
  Anja König LinkedIn Profile  Anja König Twitter Account  Anja König News  Anja König on Facebook
Managing Director
Campbell Murray
  Campbell Murray LinkedIn Profile  Campbell Murray Twitter Account  Campbell Murray News  Campbell Murray on Facebook
Managing Director
Steven Weinstein
  Steven Weinstein LinkedIn Profile  Steven Weinstein Twitter Account  Steven Weinstein News  Steven Weinstein on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Novartis Venture Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

Novartis Institutes for BioMedical Research | Novation Companies

 

Share this article

 


About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading supplier of corporate VC funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary